NCT07308418Completed
The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare gait speed, cadence, stride length, usability, and safety. It is a low-risk pilot study meant to generate first evidence for future research.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 16 (actual)
- First submitted
- 1 Dec 2025
- Start date
- 10 Jan 2026
- Primary completion date
- 18 Mar 2026
- Lead sponsor
- Magnes AG
- Diseases
- Parkinson disease
- NCT number
- NCT07308418
What you commit to
- Study type: Interventional
- Participants enrolled: 16
- From 10 Jan 2026 to the primary completion date, 18 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other neurological, orthopaedic or internal medical conditions that significantly affect walking
Other
- Atypical or secondary Parkinsonism
- Sensory disturbances in the feet (e.g. polyneuropathy).
- Cognitive impairments that interfere with understanding the study information or following instructions
Who the study is looking for
- A medically confirmed diagnosis of Parkinson's disease on the physiotherapy prescription.
- Stable medication for at least four weeks (no change in dopaminergic therapy).
- The ability to walk at least 200 metres without stopping.
- Minimum age: 18 years
- Sufficient knowledge of German to understand the study information and complete the questionnaires.
- Written informed consent form
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Magnes AG Coordinator of this site? Confirm its status | Zurich | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.